Latest News

On 26 January, Professor Kathryn Taubert delivered a statement during discussions on the Global Shortage of Essential Medicines and Vaccines at the 140th Session of the World Health Organization Executive Board (or ‘EB 140’) in Geneva. The World Heart Federation statement she delivered focused on: Patient needs for CVD medicines, especially in LMICs […]

26 January is International Kawasaki Disease Awareness Day: a day dedicated to promoting Kawasaki Disease, understanding its symptoms and driving the urgent need for early diagnosis to save children’s hearts Kawasaki Disease primarily affects young children at disease onset, though it can affect people at any age. The impacts of Kawasaki Disease for many […]

During today’s very first session of the 140th WHO Executive Board, it has been confirmed that rheumatic heart disease (RHD) shall be included as an Agenda Item at EB 141 in May 2017. RHD confirmed for discussion at EB 141 During today’s very first session of the 140th WHO Executive Board, it has been confirmed […]

The World Heart Federation is delighted to launch a new resource for our member community: CVD Advocacy Toolkit: The Road to 2018. The Toolkit is packed full of information, advocacy resources and practical guidance for all members who wish to engage in the lead-up to the United Nations High-Level Meeting on NCDs in 2018. […]

Think of the United Nations and what image springs to mind? Blue-helmeted peacekeepers, trying to control conflict situations? Multilingual technocrats in suits, out to ‘save the world’? A hot topic for today’s finger-pointing politicians? Popular perceptions of the United Nations can vary hugely, and often eclipse the UN’s basic function as an international organization made […]

WHF Advocacy Team are taking part in RHD Meeting From 13-16 January, the World Heart Federation Advocacy Team will be participating in ‘Rheumatic Heart Disease: from Molecules to the Global Community’, a conference on rheumatic heart disease (RHD) held in Cairo, Egypt. Co-organized by the Aswan Heart Centre and the Pan-African Society of Cardiology (PASCAR), […]

From 23 January to 01 February 2017, the World Health Organization (WHO) will host the 140th session of the Executive Board (EB) at the WHO headquarters in Geneva, Switzerland. As always, the World Heart Federation will be participating in this meeting, with our Board Members, members of the advocacy team and WHF Sustaining Partners in […]

The 2016-2017 cohort marks the fourth year of the World Heart Federation Emerging Leaders programme and will focus on access to essential medicines. Applications are now open until 31 January. The Emerging Leaders Programme has been created by the World Heart Federation to form and develop a long-term cadre of experts who collaborate, research, and […]

From 14-18 November, WHF Policy and Advocacy Manager Joanna Markbreiter participated in the Fourth Global Symposium on Health Systems Research in Vancouver, Canada.  This year’s symposium was on the theme of ‘Resilient and responsive health systems for a changing world’ and brought together over 2,000 delegates from 101 countries. The theme of resilience comes at […]

Johanna Ralston on patients and people at the heart of health The outgoing CEO of the World Heart Federation talks about the potentially once-in-a-lifetime opportunity for the NCD community to address the fragmentation of the health system and offer joined-up solutions with people at the centre.

The World Heart Federation’s Cholesterol Roadmap is being previewed today at the American Heart Association (AHA) Scientific Sessions 2016 in New Orleans, USA. In the Roadmap the WHF calls for more awareness of healthier lifestyles and diet; increased screening and testing for cholesterol in communities; more effective initiation of statin treatment and adherence to drug […]